Notch Signaling Pathway in Neurodegeneration

Notch Signaling Pathway in Neurodegeneration

Overview

The Notch signaling pathway is an evolutionarily conserved cell-cell communication system that regulates cell fate decisions, differentiation, and survival in the nervous system. Dysregulation of Notch signaling has emerged as a critical contributor to multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). This pathway acts as a molecular switch that influences neuronal survival, glial cell activation, neuroinflammation, and proteostasis—all central mechanisms in neurodegeneration.

Key Mechanisms and Functions

• Canonical signaling cascade: Notch receptor activation by Delta-like or Jagged ligands on neighboring cells triggers sequential proteolytic cleavage events. The nicastrin-containing γ-secretase complex cleaves Notch to release the Notch intracellular domain (NICD), which translocates to the nucleus and interacts with CSL transcription factors (CBF1/RBPjκ in mammals) to regulate target gene expression. This process directly competes with amyloid-β precursor protein (APP) cleavage pathways, creating interdependence between Notch signaling and Alzheimer's pathology.

Notch Signaling Pathway in Neurodegeneration

Overview

The Notch signaling pathway is an evolutionarily conserved cell-cell communication system that regulates cell fate decisions, differentiation, and survival in the nervous system. Dysregulation of Notch signaling has emerged as a critical contributor to multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). This pathway acts as a molecular switch that influences neuronal survival, glial cell activation, neuroinflammation, and proteostasis—all central mechanisms in neurodegeneration.

Key Mechanisms and Functions

• Canonical signaling cascade: Notch receptor activation by Delta-like or Jagged ligands on neighboring cells triggers sequential proteolytic cleavage events. The nicastrin-containing γ-secretase complex cleaves Notch to release the Notch intracellular domain (NICD), which translocates to the nucleus and interacts with CSL transcription factors (CBF1/RBPjκ in mammals) to regulate target gene expression. This process directly competes with amyloid-β precursor protein (APP) cleavage pathways, creating interdependence between Notch signaling and Alzheimer's pathology.
• Neural stem cell maintenance and neurogenesis: Notch signaling promotes neural progenitor cell self-renewal and suppresses differentiation into mature neurons through regulation of basic helix-loop-helix transcription factors. Dysregulated Notch activity impairs adult neurogenesis in the hippocampus and subventricular zone, contributing to cognitive decline in neurodegenerative conditions and limiting endogenous repair mechanisms.
• Glial cell activation and neuroinflammation: Notch signaling modulates microglial and astrocytic activation states. Elevated Notch activity promotes pro-inflammatory microglial phenotypes that increase production of TNF-α, IL-1β, and IL-6, perpetuating neuroinflammatory cascades. Conversely, Notch inhibition can shift microglial phenotypes toward neuroprotective states, though context-dependent effects occur depending on disease stage and Notch receptor subtype.
• Protein quality control and autophagy: Notch signaling intersects with autophagic pathways critical for clearing protein aggregates. NICD regulates expression of autophagy-related genes and modulates mTOR signaling, affecting clearance of misfolded proteins including amyloid-β, tau, and α-synuclein. Impaired Notch-mediated autophagy regulation contributes to accumulation of pathological protein aggregates.
• Vascular integrity and neuroinflammation: Notch signaling stabilizes the blood-brain barrier (BBB) through endothelial-pericyte interactions. Dysregulated Notch activity increases BBB permeability, allowing peripheral immune cell infiltration and exacerbating neuroinflammation—a hallmark of multiple neurodegenerative diseases.

Relevance to Neurodegeneration and Disease

The Notch pathway's involvement in neurodegeneration operates through multiple interconnected mechanisms. In Alzheimer's disease, genetic and biochemical evidence demonstrates that elevated Notch signaling correlates with increased amyloid pathology. The γ-secretase complex processes both Notch and APP; increased Notch cleavage can divert γ-secretase activity away from pathogenic APP processing, while NICD accumulation independently promotes neuroinflammation and oxidative stress. Studies have identified Notch pathway hyperactivation in the brains of AD patients and in transgenic mouse models, where pharmaceutical γ-secretase inhibition targeting Notch reduces amyloid-β accumulation but causes adverse effects through complete pathway blockade (PMID:19221146, PMID:16554755). This highlights the challenge of therapeutically targeting Notch: complete inhibition impairs cognitive function and increases mortality, whereas partial modulation may achieve neuroprotection.

In Parkinson's disease, Notch signaling regulates dopaminergic neuron differentiation and survival. Dysregulated Notch activity impairs midbrain dopaminergic development and accelerates α-synuclein accumulation through autophagy dysfunction. Microglial Notch activation promotes release of neurotoxic mediators that contribute to dopaminergic cell loss. Notch ligands, particularly Delta-like 1, control the balance between proliferation and differentiation in substantia nigra progenitor populations, and loss of this regulation contributes to reduced neurogenic capacity in PD (PMID:21876674). Additionally, Notch signaling dysfunction in astrocytes impairs their capacity to provide trophic support to vulnerable dopaminergic neurons. In amyotrophic lateral sclerosis, Notch activation in motor neurons and glial cells promotes neuroinflammatory responses that accelerate motoneuron degeneration; conditional Notch deletion in microglia extends survival in ALS mouse models. The pathway also regulates expression of survival motor neuron (SMN) protein, relevant to spinal muscular atrophy pathogenesis (PMID:24465055).

Common mechanistic themes link Notch dysregulation across neurodegenerative diseases: impaired protein quality control, excessive neuroinflammation, disrupted cell-cell communication, reduced neurogenic capacity, and compromised BBB integrity. Aging, which universally increases neurodegeneration risk, is associated with progressive dysregulation of Notch signaling in neural stem cells and glial cells, suggesting age-dependent pathway dysfunction as a fundamental contributor to neurodegeneration.

Current Research Directions

• Isoform-selective therapeutic modulation: Rather than complete γ-secretase inhibition, research increasingly focuses on Notch isoform-selective targeting strategies. Notch1 and Notch3 appear to have distinct and sometimes opposing roles in neurodegeneration; selective inhibition of pathogenic isoforms while preserving neuroprotective Notch signaling represents an emerging therapeutic frontier. Novel γ-secretase modulators (GSMs) that preferentially affect APP processing while sparing Notch are under investigation, as are substrate-selective protease inhibitors targeting specific Notch proteolytic events (PMID:28341783).
• Notch signaling in glial cell reprogramming and disease-associated phenotypes: Investigation of how Notch activation drives microglia and astrocytes toward pro-inflammatory, disease-associated phenotypes offers opportunities for therapeutic intervention. Recent work indicates that Notch inhibition in microglia can promote neuroprotective phenotypes and reduce neuroinflammation in multiple neurodegenerative disease models, though translating these findings to clinical efficacy remains challenging.
• Cell-cell communication networks and intercellular signaling: Emerging research emphasizes Notch's role in coordinating communication between neurons, glia, vascular cells, and immune cells. Single-cell transcriptomics and spatial transcriptomics approaches are revealing how cell-type-specific Notch activity patterns contribute to disease progression, opening possibilities for cell-type-targeted therapeutic interventions or approaches utilizing engineered cells with modulated Notch signaling.

References

• PMID:19221146 - Foundational work on γ-secretase inhibition and Notch pathway in Alzheimer's disease
• PMID:16554755 - Comprehensive review of presenilin function in Notch and APP processing
• PMID:21876674 - Notch signaling in dopaminergic neuron development and Parkinson's disease
• PMID:24465055 - Notch pathway involvement in motor neuron diseases and ALS
• PMID:28341783 - γ-secretase modulators and substrate-selective protease inhibition strategies

Mechanism Overview

Pathway Diagram

The following diagram shows the key molecular relationships involving Notch Signaling Pathway in Neurodegeneration discovered through SciDEX knowledge graph analysis: